Petros Pharmaceuticals is a New York-based biopharmaceutical firm that develops and markets novel therapies to treat Peyronie's disease and hormone health disorders for men.
Business Model:
Revenue: $5.8M
Employees: 11-50
Address: 1185 Avenue Of The Americas
City: New York
State: NY
Zip: 10036
Country: US
Petros Pharmaceuticals is a New York-based biopharmaceutical firm that develops and markets novel therapies to treat Peyronie's disease and hormone health disorders for men.
Contact Phone:
+19732420005
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
12/2/2020
Ticker Symbol:
PTPI
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2021 | Private Placement | $10M | 12/2021 | Post-IPO Equity | $7.5M | 11/2021 | Post-IPO Equity | $10M | 1/2016 | Venture Round | 1 | - |
Juggernaut Capital Partners Juggernaut Capital Partners |
10/2021 | Post-IPO Equity | $5.7M | 1/2016 | Venture Round | 1 | - |
Juggernaut Capital Partners Juggernaut Capital Partners |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|